vs
MAXCYTE, INC.（MXCT）与RETRACTABLE TECHNOLOGIES INC（RVP）财务数据对比。点击上方公司名可切换其他公司
RETRACTABLE TECHNOLOGIES INC的季度营收约是MAXCYTE, INC.的2.0倍（$9.4M vs $4.8M），RETRACTABLE TECHNOLOGIES INC净利率更高（-24.9% vs -200.5%，领先175.6%），RETRACTABLE TECHNOLOGIES INC同比增速更快（4.0% vs -20.9%），过去两年RETRACTABLE TECHNOLOGIES INC的营收复合增速更高（11.5% vs -7.4%）
MaxCyte Inc.是一家全球化生物技术企业，专注于开发细胞工程平台及细胞与基因治疗领域的赋能技术。其专利非病毒细胞修饰系统被制药、生物技术及生命科学研究机构广泛采用，支持免疫疗法、基因编辑疗法及下一代生物药从临床前到商业化的全流程研发。
Retractable Technologies Inc是一家专业医疗设备制造商，主打可回缩注射器、安全针头、静脉导管等一次性安全医疗产品，客户覆盖医疗机构、制药企业及公共卫生部门，产品可有效降低医护人员与患者的针刺伤害风险。
MXCT vs RVP — 直观对比
营收规模更大
RVP
是对方的2.0倍
$4.8M
营收增速更快
RVP
高出25.0%
-20.9%
净利率更高
RVP
高出175.6%
-200.5%
两年增速更快
RVP
近两年复合增速
-7.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.8M | $9.4M |
| 净利润 | $-9.6M | $-2.3M |
| 毛利率 | — | -16.2% |
| 营业利润率 | -234.5% | -81.7% |
| 净利率 | -200.5% | -24.9% |
| 营收同比 | -20.9% | 4.0% |
| 净利润同比 | 9.4% | -162.3% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MXCTRVP
| Q4 25 | $4.8M | $9.4M | ||
| Q3 25 | $4.6M | $10.1M | ||
| Q2 25 | $5.8M | $10.4M | ||
| Q1 25 | $5.7M | $8.3M | ||
| Q4 24 | $6.1M | $9.1M | ||
| Q3 24 | $5.6M | $10.3M | ||
| Q2 24 | $5.0M | $6.0M | ||
| Q1 24 | $5.6M | $7.6M |
净利润MXCTRVP
| Q4 25 | $-9.6M | $-2.3M | ||
| Q3 25 | $-12.4M | $371.0K | ||
| Q2 25 | $-12.4M | $-87.5K | ||
| Q1 25 | $-10.3M | $-10.5M | ||
| Q4 24 | $-10.6M | $3.8M | ||
| Q3 24 | $-11.6M | $-1.9M | ||
| Q2 24 | $-9.4M | $-14.2M | ||
| Q1 24 | $-9.5M | $429.4K |
毛利率MXCTRVP
| Q4 25 | — | -16.2% | ||
| Q3 25 | — | 16.7% | ||
| Q2 25 | — | -1.0% | ||
| Q1 25 | — | -0.0% | ||
| Q4 24 | — | -27.5% | ||
| Q3 24 | — | -0.1% | ||
| Q2 24 | — | -7.0% | ||
| Q1 24 | — | 25.0% |
营业利润率MXCTRVP
| Q4 25 | -234.5% | -81.7% | ||
| Q3 25 | -307.4% | -36.2% | ||
| Q2 25 | -244.3% | -49.1% | ||
| Q1 25 | -214.1% | -56.4% | ||
| Q4 24 | -213.1% | -79.6% | ||
| Q3 24 | -250.4% | -49.6% | ||
| Q2 24 | -241.0% | -95.6% | ||
| Q1 24 | -219.8% | -39.3% |
净利率MXCTRVP
| Q4 25 | -200.5% | -24.9% | ||
| Q3 25 | -269.7% | 3.7% | ||
| Q2 25 | -212.2% | -0.8% | ||
| Q1 25 | -178.7% | -126.6% | ||
| Q4 24 | -175.0% | 41.6% | ||
| Q3 24 | -205.9% | -18.6% | ||
| Q2 24 | -188.8% | -234.9% | ||
| Q1 24 | -170.6% | 5.7% |
每股收益（稀释后）MXCTRVP
| Q4 25 | — | $-0.09 | ||
| Q3 25 | $-0.12 | $0.01 | ||
| Q2 25 | $-0.12 | $0.00 | ||
| Q1 25 | — | $-0.35 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | $-0.11 | $-0.07 | ||
| Q2 24 | $-0.09 | $-0.48 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $103.0M | $2.6M |
| 总债务越低越好 | — | $895.6K |
| 股东权益账面价值 | $171.5M | $74.4M |
| 总资产 | $202.5M | $142.6M |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资MXCTRVP
| Q4 25 | $103.0M | $2.6M | ||
| Q3 25 | $105.7M | $3.4M | ||
| Q2 25 | $126.6M | $3.0M | ||
| Q1 25 | $138.3M | $3.4M | ||
| Q4 24 | $154.5M | $4.2M | ||
| Q3 24 | $153.8M | $3.9M | ||
| Q2 24 | $157.3M | $6.9M | ||
| Q1 24 | $157.5M | $10.0M |
总债务MXCTRVP
| Q4 25 | — | $895.6K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MXCTRVP
| Q4 25 | $171.5M | $74.4M | ||
| Q3 25 | $180.3M | $76.8M | ||
| Q2 25 | $190.7M | $76.5M | ||
| Q1 25 | $199.4M | $76.6M | ||
| Q4 24 | $206.3M | $87.2M | ||
| Q3 24 | $213.3M | $83.5M | ||
| Q2 24 | $221.3M | $85.4M | ||
| Q1 24 | $226.4M | $99.7M |
总资产MXCTRVP
| Q4 25 | $202.5M | $142.6M | ||
| Q3 25 | $213.5M | $146.4M | ||
| Q2 25 | $219.8M | $147.1M | ||
| Q1 25 | $230.0M | $149.3M | ||
| Q4 24 | $239.5M | $160.7M | ||
| Q3 24 | $248.6M | $157.8M | ||
| Q2 24 | $251.5M | $160.7M | ||
| Q1 24 | $257.9M | $176.0M |
负债/权益比MXCTRVP
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.7M | $-596.5K |
| 自由现金流经营现金流 - 资本支出 | $-2.9M | — |
| 自由现金流率自由现金流/营收 | -61.0% | — |
| 资本支出强度资本支出/营收 | 4.8% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-36.2M | — |
8季度趋势，按日历期对齐
经营现金流MXCTRVP
| Q4 25 | $-2.7M | $-596.5K | ||
| Q3 25 | $-7.5M | $-1.3M | ||
| Q2 25 | $-9.9M | $-3.7M | ||
| Q1 25 | $-14.4M | $-1.5M | ||
| Q4 24 | $-7.8M | $-1.1M | ||
| Q3 24 | $-4.4M | $-5.7M | ||
| Q2 24 | $-4.8M | $-2.7M | ||
| Q1 24 | $-10.6M | $-2.0M |
自由现金流MXCTRVP
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $-7.8M | $-1.3M | ||
| Q2 25 | $-10.4M | $-4.1M | ||
| Q1 25 | $-15.1M | $-1.6M | ||
| Q4 24 | $-8.0M | $-1.4M | ||
| Q3 24 | $-4.8M | $-6.5M | ||
| Q2 24 | $-5.1M | $-2.8M | ||
| Q1 24 | $-11.4M | $-2.2M |
自由现金流率MXCTRVP
| Q4 25 | -61.0% | — | ||
| Q3 25 | -168.5% | -13.4% | ||
| Q2 25 | -179.2% | -38.9% | ||
| Q1 25 | -262.3% | -18.8% | ||
| Q4 24 | -131.6% | -15.5% | ||
| Q3 24 | -85.5% | -63.0% | ||
| Q2 24 | -103.3% | -46.8% | ||
| Q1 24 | -203.6% | -29.6% |
资本支出强度MXCTRVP
| Q4 25 | 4.8% | — | ||
| Q3 25 | 6.5% | 0.9% | ||
| Q2 25 | 10.0% | 3.2% | ||
| Q1 25 | 11.4% | 1.0% | ||
| Q4 24 | 2.4% | 3.3% | ||
| Q3 24 | 7.2% | 7.7% | ||
| Q2 24 | 5.9% | 2.0% | ||
| Q1 24 | 14.4% | 3.0% |
现金转化率MXCTRVP
| Q4 25 | — | — | ||
| Q3 25 | — | -3.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -4.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MXCT
| Products | $4.2M | 87% |
| Other | $634.0K | 13% |
RVP
暂无分部数据
